ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1057 • 2017 ACR/ARHP Annual Meeting

    Budgetary Impact Analysis of Real-World Dosing Patterns in Matched Cohorts of Rheumatoid Arthritis Patients Treated with Infliximab or Golimumab Intravenous Anti-TNF Medications

    Lorie A. Ellis1, Elisabetta Malangone-Monaco2, Helen Varker2, Diana Stetsovsky3, Maureen Kubacki4, Raphael J. DeHoratius5 and Shelly Kafka4, 1Janssen HECOR Immunology, Horsham, PA, 2Truven Health Analytics, Bethesda, MD, 3Truven Health Analytics, Philadelphia, PA, 4Janssen Scientific Affairs, LLC, Horsham, PA, 5Janssen Scientific Affairs, LLC/Sidney Kimmel School of Medicine, Thomas Jefferson University, Horsham/Philadelphia, PA

    Background/Purpose: Infliximab (IFX) is more frequently selected than golimumab for intravenous use (GLM-IV) in patients with Rheumatoid Arthritis (RA) but differences in dosing and administration…
  • Abstract Number: 1058 • 2017 ACR/ARHP Annual Meeting

    Variation in DMARD Therapy Following Methotrexate Failure for Newly-Identified Rheumatoid Arthritis in a National Veterans Health Administration Cohort

    John McDougall Jr.1,2, Cynthia Brandt3,4, Melissa Skanderson3, Joseph Goulet3 and Liana Fraenkel5, 1National Clinican Scholars Program, Yale School of Medicine, New Haven, CT, 2Dep't. of Rheumatology, Yale School of Medicine, New Haven, CT, 3Veterans Affairs Connecticut Healthcare System, West Haven, CT, 4Emergency Medicine, Yale School of Medicine, New Haven, CT, 5Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT

    Background/Purpose: Absent contraindications to conventional DMARD (cDMARD) use, the Veterans Administration (VA) requires a 3-month trial of 2 cDMARDs prior to the use of biologic…
  • Abstract Number: 1059 • 2017 ACR/ARHP Annual Meeting

    Cost-Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis

    John B. Wong1, Mei Chung2, Lori Lyn Price3 and Chenchen Wang4,5, 1Tufts Medical Center, Boston, MA, 2Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, 3Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 4Rheumatology, Center of Integrative Medicine and Division of Rheumatology, Tufts Medical Center, Boston, MA, Boston, MA, 5Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: A single-blind randomized comparative effectiveness trial showed that Tai Chi yielded beneficial effects similar to those of a standard course of physical therapy in…
  • Abstract Number: 1060 • 2017 ACR/ARHP Annual Meeting

    Assessing Interferon Regulatory Factor 5 (IRF5) Function in Human Primary Immune Cells with Cell-Penetrating Peptides

    Jaspreet Banga1, Dinesh Srinivasan2, Chia Chi Sun3, Francesca Milletti4, Kuo-Sen Huang5, Shannon Hamilton6, Ann F. Hoffman5, Yajuan G. Qin2, Sandip Panicker2, Gang Lu2, Dan Li7, Hong Qian5, David R. Bolin5, Lena Liang5, Charles Wartchow5, Nader Fotouhi5, Julie A. DeMartino3, Seng-Lai Tan2, Gang Chen3 and Betsy J. Barnes7, 1The Feinstein Institute for Medical Research, Manhasset, NY, 2Inflammation Discovery, Hoffmann-La Roche, Inc., Nutley, NJ, 3TIP Immunology, EMD Serono Research and Development Institute, Inc., Billerica, MA, 4Roche Innovation Center New York, New York, NY, 5Hoffmann-La Roche, Inc., Nutley, NJ, 6Hoffmann-La Roche, Inc., Nutley, NJ, Afghanistan, 7Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Interferon regulatory factor 5 (IRF5) is a key mediator of pathogen-induced immune responses that acts downstream of Toll-like receptors (TLRs), NOD-like receptors (NLRs) and…
  • Abstract Number: 1061 • 2017 ACR/ARHP Annual Meeting

    Cardiac Endothelial Cell Transcriptome Analyses Support a Pathological Role of Metabolic and Inflammasome Genes in Anti-SSA/Ro-Associated Congenital Heart Block

    Sara Rasmussen1, Robert M. Clancy2 and Jill P. Buyon2, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2NYU School of Medicine, New York, NY

    Background/Purpose: The role of Type I IFN in anti-SSA/Ro-associated Congenital Heart Block (CHB) may include an adverse consequence to the cardiac vasculature. One scenario consistent…
  • Abstract Number: 1062 • 2017 ACR/ARHP Annual Meeting

    Ptpn22 Regulates Synovial Slam Family Receptor Expression during Toll-like Receptor-Driven Suppression of Inflammatory Arthritis

    David Ewart1, Juan Abrahante Lloréns2 and Erik J. Peterson3, 1Rheumatology, University of Minnesota, Minneapolis, MN, 2Informatics Institute (UMII), University of Minnesota, Minneapolis, MN, 3Center for Immunology/Department of Medicine, University of Minnesota, Minneapolis, MN

    Background/Purpose: Genetic factors contribute strongly to Rheumatoid arthritis (RA) risk. Protein tyrosine phosphatase non-receptor 22 [PTPN22] encodes the hematopoietic-specific Lymphoid Phosphatase [“Lyp”].  A PTPN22 coding…
  • Abstract Number: 1063 • 2017 ACR/ARHP Annual Meeting

    Activation of Toll-like Receptor 2 in Human Synovium Explants Increase Tissue Turnover and Secretion of Interleukin-6

    Neha Sharma1,2, Ashref Kayed3,4, Cecilie F. Kjelgaard-Petersen2,5, Thorbjørn G. Christiansen6, Morten Karsdal7, Christian S. Thudium2 and Anne-C. Bay-Jensen8, 1Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark, 2Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 3Biomolecular Sciences, University of Copenhagen, Copenhagen, Denmark, 4Research and Biomarkers, Nordic Bioscience, Herlev, Denmark, 5Bioengineering, Technical University of Denmark, Kgs. Lyngby, Denmark, 6Gentofte University Hospital, Orthopaedicsurgery unit, Gentofte, Denmark, 7Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark, 8Biomarkers and Reseach, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: The innate immune system is important for initiation and development of OA. Increased degradation of the cartilage release fragments into the synovial fluid, which…
  • Abstract Number: 1064 • 2017 ACR/ARHP Annual Meeting

    Characterization of Human Tolerogenic Dendritic Cells Generated with Protein Kinase C Inhibitor and Induction from Patients with Autoimmune Diseases

    Hitoshi Hasegawa1, Takuya Matsumoto1, Endy Adnan2, Jun Ishizaki1, Koichiro Suemori1 and Masaki Yasukawa1, 1Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan, 2Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan

    Background/Purpose: Tolerogenic dendritic cells (tDCs) are a promising therapeutic tool for specific induction of immunological tolerance. Human tDCs can be generated ex vivo using various…
  • Abstract Number: 1065 • 2017 ACR/ARHP Annual Meeting

    Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus Is Realted to an Intrinsic Defect in the Ca2+/Calcineurin/NFAT1 Signaling Pathway

    Yong-Wook Park1, Young-Nan Cho2, Hye-Mi Jin1, Tae-Jong Kim3 and Seung-Jung Kee4, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 2Rheumatology, Chonnam National University Hospital and Medical School, Gwangju, MN, Korea, Republic of (South), 3Chonnam Nat`l University Medical School&Hospital, Chonnam, Korea, Republic of (South), 4Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)

    Background/Purpose: Mucosal-associated invariant T (MAIT) cells contribute to protection against certain microorganism infections and play an important role in mucosal immunity. However, the role of…
  • Abstract Number: 1066 • 2017 ACR/ARHP Annual Meeting

    Invention and Phenotypic Evaluation of Human IgG4-Knock-in Mice

    Yoshie Gon, Hajime Yoshifuji, Koji Kitagori, Toshiki Nakajima, Kosaku Murakami, Ran Nakashima, Koichiro Ohmura and Tsuneyo Mimori, Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Background/Purpose: IgG4-related disease (IgG4-RD) is a disorder characterized by elevated serum IgG4 concentration and infiltration of IgG4-positive plasma cells into affected organs, however, the role…
  • Abstract Number: 1067 • 2017 ACR/ARHP Annual Meeting

    Clinical Significance of Anti-Dense Fine Speckled 70 and Dense Fine Speckled Pattern in Diagnosis of Systemic Autoimmune Rheumatic Disease

    You La Jeon1, Ji Yun Ryu1, Jiyoung Baek1, Woo-In Lee2, Myeong Hee Kim1 and So Young Kang1, 1Department of Laboratory Medicine, School of Medicine, Kyung Hee University and Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of (South), 2School of Medicine, Kyung Hee University and Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of (South)

    Background/Purpose: The dense fine speckled (DFS) pattern in IIF-ANA on HEp-2 cell is perhaps the most frequently observed pattern in most clinical laboratories. The DFS70…
  • Abstract Number: 1068 • 2017 ACR/ARHP Annual Meeting

    Impact of TNF Antagonist Treatment on the Gut Microbiome In Vivo

    Odile Gabay1, Jonathan Vicenty2, Grant Wunderlin3, Linda Tiffany2, Wells Wu4, Vahan Simonyan5 and Kathleen A Clouse6, 1Office of Biotechnology Products /Center for Drug Evaluation and Research DBRRI, U.S. Food and Drug Administration, Silver Spring, MD, 2Office of Biotechnology Products, Center for Drug Evaluation and Research, DBRRI, U.S. Food and Drug Administration, Silver Spring, MD, 3Center for Drug Evaluation and Research CDER DBRRI, U.S. Food and Drug Administration, Silver Spring, MD, 4Center for Biologic Evaluation and Research OMPT, U.S. Food and Drug Administration, Silver Spring, MD, 5Center for Biologic Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 6Office of Biotechnology Products /Center for Drug Evaluation and Research,DBRRI, U.S. Food and Drug Administration, Silver Spring, MD

    Background/Purpose: Auto-immune diseases are in constant progression in the US. Biologic therapeutics have been used successfully to treat these diseases, but have presented some unique…
  • Abstract Number: 1069 • 2017 ACR/ARHP Annual Meeting

    Significantly Elevated Serum Protein-Adduction with 4-Hydroxy-2-Nonenal but Not Malondialdehyde in Sjogren’s Syndrome

    Biji T Kurien1,2,3, Sona Nuguri4, Bre'ana Byrd5, Joey Maher6, Rohit Thomas4, Huyen Tran7 and R. Hal Scofield8, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 3College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Oklahoma School of Science and Mathematics, Oklahoma City, OK, 5University of Central Oklahoma, Edmond, OK, 6University of Oklahoma, Norman, OK, 7University of Oklahoma Health Sciences Center, Edmond, OK, 8Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic inflammatory, autoimmune disorder characterized by diminished lacrimal and salivary gland secretion resulting in keratoconjunctivitis sicca and xerostomia. Autoantibodies,…
  • Abstract Number: 1070 • 2017 ACR/ARHP Annual Meeting

    Phenotypic Characterization of Peripheral Basophil Perturbations in the Antiphospholipid Syndrome

    Benjamin Chaigne1, Veronique Le Guern2, Tali-Anne Szwebel1, Romain Paule2, Claire Le Jeunne3, Nathalie Costedoat-Chalumeau4 and Luc Mouthon5, 1Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d’Ile de France, hôpital Cochin, DHU Authors, Assistance Publique-Hôpitaux de Paris, Paris, France, 2Department of Internal Medicine, Department of Internal Medicine, Cochin University Hospital, Paris, France, 3Service de Médecine Interne, Hôpital Cochin, Centre de référence national pour les maladies systémiques autoimmunes rares d’Ile de France, DHU Authors, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, Paris, France, 4Service de médecine interne Pôle médecine, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares de l’île de France, Paris, France, 5Service de Médecine Interne, Hôpital Cochin, Centre de référence national pour les maladies systémiques autoimmunes rares d’Ile de France, DHU Authors, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France ;Université Paris Descartes Sorbonne Paris, Paris, France

    Background/Purpose: The antiphospholipid syndrome (APS) is an autoimmune condition characterized by thrombosis, pregnancy complications and the presence of antiphospholipid antibodies. Basophils, which have long been…
  • Abstract Number: 1071 • 2017 ACR/ARHP Annual Meeting

    Increased Susceptibility of SLE-Prone Mice to Pulmonary Haemophilus Influenzae Infection Was Attributed to Dysfunctions of Innate Immune Responses

    Wenchao Li and Lingyun Sun, Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

    Background/Purpose: Aside from the disease itself, infections represent the major cause of morbidity and mortality in systemic lupus erythematosus (SLE) patients. Although the daily usage…
  • « Previous Page
  • 1
  • …
  • 1274
  • 1275
  • 1276
  • 1277
  • 1278
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology